DGX241115C160000
- 0.05
- -0.92-94.85%
Quest Diagnostics Newsroom
Quest Diagnostics To Go Ex-Dividend On January 14th, 2025 With 0.75 USD Dividend Per Share
November 13th (Eastern Time) - $Quest Diagnostics(DGX.US)$ is trading ex-dividend on January 14th, 2025.Shareholders of record on January 14th, 2025 will receive 0.75 USD dividend per share on
All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy
Is Quest Diagnostics Stock a Smart Addition to Your Portfolio Now?
Quest Diagnostics Declares Quarterly Cash Dividend
Press Release: Quest Diagnostics Declares Quarterly Cash Dividend
PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up
How Is The Market Feeling About Quest Diagnostics?
Is Now An Opportune Moment To Examine Quest Diagnostics Incorporated (NYSE:DGX)?
BDX Stock Gains Following Q4 Earnings Beat and Higher Margins
Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises
Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates
INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts
Mizuho Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Equillium (EQ), Quest Diagnostics (DGX) and Alnylam Pharma (ALNY)
Here's Why You Should Retain DGX Stock in Your Portfolio Now
Quest Diagnostics Insider Sold Shares Worth $278,525, According to a Recent SEC Filing
Quest Diagnostics Analyst Ratings
Piper Sandler Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $165
Piper Sandler Reaffirms Their Hold Rating on Quest Diagnostics (DGX)
Quest Diagnostics Incorporated (NYSE:DGX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year